Targeting T Cells: New Paradigms in the Treatment of Lymphoproliferative Disorders and Transplantation
Preceding the 48th Annual Meeting of the American Society of Hematology

 
 

Target Audience
This course is designed for oncologists and hematologists.

Educational Objectives
After completing this course, you should be able to:

  • Describe the pathophysiology of aggressive T cell-mediated lymphoproliferative disease.
  • Evaluate research derived from pre-clinical anti-CD2 T cell models.
  • Identify clinical applications of MAb therapies and their effect on organ transplantation.
  • Define the clinical application of CD2-mediated T cell-depletion in the treatment
    of non-Hodgkin’s lymphoma (NHL), organ transplantation and other cancers.
  • Recognize the need for ongoing research in T cell-mediated MAb therapy.
 
 
ACCREDITATION: This activity has been planned and implemented in accordance with the Essential Areas and policies of
the Accreditation Council for Continuing Medical Education through the joint sponsorship of Vindico Medical Education
and Hem/Onc Today. Vindico Medical Education is accredited by the ACCME to provide continuing medical education
for physicians.

CREDIT DESIGNATION: Vindico Medical Education designates this educational activity for a maximum of 2.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

FACULTY/PLANNER DISCLOSURE POLICY: In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience.

NOTICE: Faculty, topics, program schedule, and credit hours are subject to change. Audio taping or video taping is prohibited without written permission from the program director and the Office of Medical Education and Compliance.

 
     
 
Home Agenda Faculty Registration